Human growth hormone

Sort By

Recombinant Human Growth Hormone (rHGH) from Bioniche Pharma reflects cutting-edge biotechnological peptide synthesis. Developed through sophisticated recombinant DNA techniques in dedicated expression hosts, our somatropin compounds feature an exact 191-amino acid structure identical to naturally occurring human growth hormone, providing high receptor affinity and exceptional biological compatibility.

CLINICAL PHARMACOLOGY & DYNAMICS

Bioniche Pharma rHGH delivers widespread physiological action by engaging transmembrane growth hormone receptors (GHR) across target tissues. This binding triggers intracellular signaling pathways—principally driven by liver and localized synthesis of insulin-like growth factor 1 (IGF-1)—to encourage skeletal growth, enhance cellular amino acid transport, boost protein translation, stimulate lipolytic activity, and improve systemic nitrogen balance.

INDICATIONS & CLINICAL UTILITY
  • Sustained replacement management for pediatric and adult individuals with diagnosed idiopathic or acquired growth hormone deficiency (GHD).
  • Clinical treatment of growth impairment secondary to chronic kidney disease, Turner syndrome, or intrauterine growth restriction (SGA).
  • Metabolic support and tissue repair protocols for patients suffering from HIV-associated catabolic wasting or recovering from severe thermal injuries.
CONTRAINDICATIONS & GENERAL PRECAUTIONS
  • Active oncological conditions or proliferative neoplastic disease; somatropin treatment must be stopped immediately if active tumors are detected.
  • Severe critical illness resulting from open-heart surgical procedures, major abdominal surgery, multiple trauma, or acute respiratory distress syndrome.
  • Hypersensitivity or severe allergic reaction to somatropin or any inactive ingredients included in the lyophilized formulation or reconstituting solution.
SAFETY MONITORING & CLINICAL SURVEILLANCE

Routine clinical oversight during treatment should encompass regular testing of fasting glucose, glycated hemoglobin (HbA1c), thyroid profiles (TSH/free T4), and serum IGF-1 concentrations, alongside clinical screening for signs of fluid accumulation, peripheral edema, or joint pain.

STORAGE & HANDLING

Keep unconstituted Bioniche Pharma rHGH vials refrigerated at 2°C to 8°C in a dark place. Once reconstituted using bacteriostatic diluent, store in the refrigerator and use within the recommended timeframe. Protect from freezing. Keep strictly out of the reach and sight of children.